Results 31 to 40 of about 305,879 (245)
French recommendations for the management of systemic sclerosis
Orphanet Journal of Rare Diseases, 2021 Systemic sclerosis (SSc) is a generalized disease of the connective tissue, arterioles, and microvessels, characterized by the appearance of fibrosis and vascular obliteration.
Eric Hachulla +31 more
doaj +1 more source
EClinicalMedicine, 2023 Summary: Background: Systemic sclerosis is a heterogenous disease in which little is known about patterns of patient-reported symptom clusters. We aimed to identify classes of individuals with similar anxiety, depression, fatigue, sleep disturbance, and
Robyn K. Wojeck +108 more
doaj +1 more source
A rare case of hidebound disease with dental implications
Dental Research Journal, 2013 Systemic sclerosis (also called as Scleroderma or hidebound disease) is a chronic sclerotic disease of unknown etiology which causes diffuse, increased deposition of extra cellular matrix in connective tissue with vascular abnormalities, resulting in ...
Vikram Bali +3 more
doaj +1 more source
Human otopathology in scleroderma
Laryngoscope Investigative Otolaryngology, 2023 Objective Scleroderma is a complex chronic progressive immune‐mediated disease that causes fibrosis of the skin and internal organs, and vasculopathy. Ear involvement has been poorly studied in patients with scleroderma.
Melissa Castillo‐Bustamante +4 more
doaj +1 more source
Egyptian Rheumatology and Rehabilitation, 2023 Background Systemic sclerosis is an autoimmune multisystem disorder which affects the patients’ physical and psychological functioning. Scleroderma health assessment questionnaire used to measure physical disability in systemic sclerosis patients.
Samah Mahmoud Alian +3 more
doaj +1 more source
Localized scleroderma: A rare clinical entity
Journal of Indian Academy of Oral Medicine and Radiology, 2014 Localized Scleroderma (LS), which is also referred to as morphea, is an inflammatory disease that leads to diffuse or localized fibrotic and atrophic skin hardening.
Ranjana Garg +2 more
doaj +1 more source
Anais Brasileiros de Dermatologia, 2005 FUNDAMENTOS: A esclerose sistêmica é colagenose pouco comum e muito rica em manifestações cutâneas. OBJETIVO: Estudar a prevalência das manifestações cutâneas na esclerose sistêmica em geral e nos seus diferentes subtipos (formas limitada, generalizada e
Fernanda Guidolin +4 more
doaj +1 more source
Prevalence and clinical significance of cathepsin G antibodies in systemic sclerosis
Reumatismo, 2003 Objectives: To evaluate the prevalence and clinical significance of cathepsin G antibodies in patients affected with systemic sclerosis (SSc, scleroderma).
P. Grypiotis +7 more
doaj +1 more source
Arthritis Care &Research, EarlyView.Systemic sclerosis (SSc) is a rare autoimmune disease defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Despite advances in care, major complications such as interstitial lung disease (ILD) and myocardial involvement remain the leading causes of morbidity and mortality.
Cristiana Sieiro Santos +2 more
wiley +1 more source
Discordance Between Patient and Physician Global Assessments in Early Systemic Sclerosis
Arthritis Care &Research, EarlyView.Objective This study aims to identify factors associated with patient global assessment (PtGA) and physician global assessment (PhGA) and discordance between them in systemic sclerosis (SSc). Methods Data from adults with early SSc (<5 years) from the Collaborative National Quality and Efficacy Registry were included.
Ellen Romich +35 more
wiley +1 more source